about
TRP channels in schistosomesEvidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoniInhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and PraziquantelDrug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosinePraziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trialClinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trialsSingle Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled TrialToward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg ExcretionPraziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.Schistosomiasis manifesting as a colon polyp: a case report.Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor ImatinibHas the NTD community neglected evidence-based policy?Proteomic Analysis of the Schistosoma mansoni MiracidiumPopulation Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicumDisposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection.Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis.Practical dosing of praziquantel for schistosomiasis in preschool-aged children.Systematic review of studies generating individual participant data on the efficacy of drugs for treating soil-transmitted helminthiases and the case for data-sharing.Effect of phenyl vinyl sulphone cysteine protease inhibitor on Schistosoma mansoni: in vitro and in vivo experimental studies.Atypical pharmacology of schistosome TRPA1-like ion channels.A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d'Ivoire
P2860
Q26738732-96E33FC9-413B-457B-9A12-D385681549A4Q27303844-47831E8B-071B-409F-A1BF-6562E46FBA4DQ27304398-5081C212-EAC2-468C-95A1-27FD03305D09Q27304597-C06DE83A-48DD-49B1-905A-C59346DA08C7Q27339703-1BFD0F58-34EE-4320-85EE-EC4C607494E3Q28540831-77F98539-0A78-43E2-8552-1B37EB7B101DQ28545079-6620E806-CB49-46FE-B95A-F433F92D2373Q28547483-38860362-B6A0-4E1D-A78B-CD5410B28017Q28548465-B4DA780B-7526-4A76-B13B-6D36760ACE61Q33805145-EA82F882-988D-4B26-B86E-058525E3003AQ34334584-1499F0EB-E91B-45E2-B087-A97855D32884Q34705820-914BC56C-ACEE-4BB7-B2F0-C4B7430EE7EEQ34855053-C09FE371-82AB-4DD9-91B0-EEDF662FE105Q35901075-D34AEB2F-90A0-468D-9879-9CB295394631Q36099895-91D059B4-3A5A-4B24-9B1B-F50E42C7C2C5Q36485623-96F6C9AB-2FC1-48CC-A66E-D4E599A996C3Q37124226-F4DC52C5-A2FC-424C-A9AC-68F98446D78CQ37726920-3E78C90B-0764-433D-8531-E13B2C424505Q38997065-7F76B5BB-BEBA-4AB6-A2FD-C8CCA9E63F6BQ39322915-3AC580CE-BB1A-4834-87BB-065E2780CA49Q45951598-82FAB794-D373-451D-9705-2D015109C51DQ46889462-039C307F-0046-494F-B557-ABA69F81134DQ55228407-7B9F286C-D278-4E8B-B176-3B82A0D54D6EQ57143687-AA1FD954-EF60-4669-8C28-8BAA874FE6FD
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Drugs for treating Schistosoma mansoni infection
@ast
Drugs for treating Schistosoma mansoni infection
@en
Drugs for treating Schistosoma mansoni infection
@en-gb
Drugs for treating Schistosoma mansoni infection
@nl
type
label
Drugs for treating Schistosoma mansoni infection
@ast
Drugs for treating Schistosoma mansoni infection
@en
Drugs for treating Schistosoma mansoni infection
@en-gb
Drugs for treating Schistosoma mansoni infection
@nl
prefLabel
Drugs for treating Schistosoma mansoni infection
@ast
Drugs for treating Schistosoma mansoni infection
@en
Drugs for treating Schistosoma mansoni infection
@en-gb
Drugs for treating Schistosoma mansoni infection
@nl
P2093
P2860
P3181
P1476
Drugs for treating Schistosoma mansoni infection
@en
P2093
Anthony Danso-Appiah
David Sinclair
Piero L Olliaro
P2860
P304
P3181
P356
10.1002/14651858.CD000528.PUB2
P577
2013-02-28T00:00:00Z